Allworth Financial’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $251K | Buy |
1,286
+270
| +27% | +$56K | ﹤0.01% | 1361 |
|
|
2026
Q1 | $228K | Buy |
1,016
+49
| +5% | +$12.2K | ﹤0.01% | 1321 |
|
|
2025
Q4 | $233K | Sell |
967
-17
| -2% | -$4.35K | ﹤0.01% | 1272 |
|
|
2025
Q3 | $269K | Sell |
984
-98
| -9% | -$26.8K | ﹤0.01% | 1148 |
|
|
2025
Q2 | $279K | Buy |
1,082
+375
| +53% | +$89.5K | ﹤0.01% | 1042 |
|
|
2025
Q1 | $167K | Buy |
707
+33
| +5% | +$7.7K | ﹤0.01% | 1014 |
|
|
2024
Q4 | $167K | Hold |
674
| – | – | ﹤0.01% | 1018 |
|
|
2024
Q3 | $164K | Buy |
674
+27
| +4% | +$6.03K | ﹤0.01% | 882 |
|
|
2024
Q2 | $132K | Buy |
647
+139
| +27% | +$28.2K | ﹤0.01% | 964 |
|
|
2024
Q1 | $101K | Buy |
508
+30
| +6% | +$5.5K | ﹤0.01% | 1021 |
|
|
2023
Q4 | $82.2K | Buy |
478
+42
| +10% | +$6.45K | ﹤0.01% | 1016 |
|
|
2023
Q3 | $64.5K | Buy |
436
+4
| +0.9% | +$723 | ﹤0.01% | 1037 |
|
|
2023
Q2 | $94.4K | Sell |
432
-2
| -0.5% | -$446 | ﹤0.01% | 916 |
|
|
2023
Q1 | $95K | Sell |
434
-19
| -4% | -$4.12K | ﹤0.01% | 873 |
|
|
2022
Q4 | $94.2K | Sell |
453
-77
| -15% | -$16.9K | ﹤0.01% | 830 |
|
|
2022
Q3 | $116K | Buy |
530
+90
| +20% | +$20.5K | ﹤0.01% | 726 |
|
|
2022
Q2 | $92K | Buy |
440
+58
| +15% | +$12.3K | ﹤0.01% | 741 |
|
|
2022
Q1 | $93K | Buy |
382
+129
| +51% | +$31.2K | ﹤0.01% | 745 |
|
|
2021
Q4 | $66K | Sell |
253
-44
| -15% | -$11.4K | ﹤0.01% | 777 |
|
|
2021
Q3 | $78K | Buy |
297
+47
| +19% | +$12.9K | ﹤0.01% | 674 |
|
|
2021
Q2 | $62K | Hold |
250
| – | – | ﹤0.01% | 565 |
|
|
2021
Q1 | $49K | Hold |
250
| – | – | ﹤0.01% | 581 |
|
|
2020
Q4 | $53K | Hold |
250
| – | – | ﹤0.01% | 473 |
|
|
2020
Q3 | $43K | Hold |
250
| – | – | ﹤0.01% | 448 |
|
|
2020
Q2 | $48K | Hold |
250
| – | – | ﹤0.01% | 429 |
|
|
2020
Q1 | $37K | Hold |
250
| – | – | ﹤0.01% | 451 |
|
|
2019
Q4 | $39K | Buy |
+250
| New | +$36K | ﹤0.01% | 408 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$6K | – | 810 |
|
|
2016
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 468 |
|
|
2016
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 474 |
|
|
2016
Q2 | $6K | Buy |
+100
| New | +$5.89K | ﹤0.01% | 438 |
|
Other funds holding RMD
Allworth Financial's RMD Position: Q2 2026 in Review
Allworth Financial increased its ResMed (RMD) stake by 27% in Q2 2026, buying an estimated $56K and bringing the position to 1,286 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.
Allworth Financial first reported a position in RMD in Q2 2016 and has held it in 30 quarters since. The position peaked at $279K in Q2 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Allworth Financial held 1,286 shares of ResMed worth $251K as of Q2 2026.
- Allworth Financial bought 270 ResMed shares in Q2 2026, an estimated $56K.
- ResMed made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1361 holding.
- Allworth Financial first reported a position in ResMed in Q2 2016 and has held it in 30 quarters since.
- Allworth Financial's ResMed position peaked at $279K in Q2 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.